0.20Open0.19Pre Close54 Volume991 Open Interest5.00Strike Price1.06KTurnover90.16%IV7.74%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.3657Delta0.7097Gamma38.24Leverage Ratio-0.0190Theta0.0002Rho13.98Eff Leverage0.0022Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet